Sort   by:  
 Page size 
UnknownBiomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells.
Not available
S-EPMC5951172 | biostudies-literature
UnknownInsulin-Like Growth Factor Is Associated with Changes in Body Composition with Antiretroviral Therapy Initiation.
Not available
S-EPMC5576217 | biostudies-literature
UnknownClinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.
Not available
S-EPMC3719905 | biostudies-literature
UnknownRotational thromboelastometry alongside conventional coagulation testing in patients with Crimean-Congo haemorrhagic fever: an observational cohort study.
Not available
S-EPMC7641897 | biostudies-literature
UnknownScreening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253.
Not available
S-EPMC3923622 | biostudies-literature
UnknownIsoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings.
Not available
S-EPMC9314898 | biostudies-literature
UnknownCorrelates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.
Not available
S-EPMC7347076 | biostudies-literature
UnknownEfavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
Not available
S-EPMC9890454 | biostudies-literature
UnknownEffect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial.
Not available
S-EPMC6265110 | biostudies-literature
UnknownImmunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial.
Not available
S-EPMC11789733 | biostudies-literature
Sort   by:  
 Page size